Cargando…
Prognostic value of tumor necrosis based on the evaluation of frequency in invasive breast cancer
BACKGROUND: Tumor necrosis (TN) was associated with poor prognosis. However, the traditional classification of TN ignored spatial intratumor heterogeneity, which may be associated with important prognosis. The purpose of this study was to propose a new method to reveal the hidden prognostic value of...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257329/ https://www.ncbi.nlm.nih.gov/pubmed/37296414 http://dx.doi.org/10.1186/s12885-023-10943-x |
_version_ | 1785057279785041920 |
---|---|
author | Chen, Jianhua Li, Zhijun Han, Zhonghua Kang, Deyong Ma, Jianli Yi, Yu Fu, Fangmeng Guo, Wenhui Zheng, Liqin Xi, Gangqin He, Jiajia Qiu, Lida Li, Lianhuang Zhang, Qingyuan Wang, Chuan Chen, Jianxin |
author_facet | Chen, Jianhua Li, Zhijun Han, Zhonghua Kang, Deyong Ma, Jianli Yi, Yu Fu, Fangmeng Guo, Wenhui Zheng, Liqin Xi, Gangqin He, Jiajia Qiu, Lida Li, Lianhuang Zhang, Qingyuan Wang, Chuan Chen, Jianxin |
author_sort | Chen, Jianhua |
collection | PubMed |
description | BACKGROUND: Tumor necrosis (TN) was associated with poor prognosis. However, the traditional classification of TN ignored spatial intratumor heterogeneity, which may be associated with important prognosis. The purpose of this study was to propose a new method to reveal the hidden prognostic value of spatial heterogeneity of TN in invasive breast cancer (IBC). METHODS: Multiphoton microscopy (MPM) was used to obtain multiphoton images from 471 patients. According to the relative spatial positions of TN, tumor cells, collagen fibers and myoepithelium, four spatial heterogeneities of TN (TN1-4) were defined. Based on the frequency of individual TN, TN-score was obtained to investigate the prognostic value of TN. RESULTS: Patients with high-risk TN had worse 5-year disease-free survival (DFS) than patients with no necrosis (32.5% vs. 64.7%; P < 0.0001 in training set; 45.8% vs. 70.8%; P = 0.017 in validation set), while patients with low-risk TN had a 5-year DFS comparable to patients with no necrosis (60.0% vs. 64.7%; P = 0.497 in training set; 59.8% vs. 70.8%; P = 0.121 in validation set). Furthermore, high-risk TN “up-staged” the patients with IBC. Patients with high-risk TN and stage I tumors had a 5-year DFS comparable to patients with stage II tumors (55.6% vs. 62.0%; P = 0.565 in training set; 62.5% vs. 66.3%; P = 0.856 in validation set), as well as patients with high-risk TN and stage II tumors had a 5-year DFS comparable to patients with stage III tumors (33.3% vs. 24.6%; P = 0.271 in training set; 44.4% vs. 39.3%; P = 0.519 in validation set). CONCLUSIONS: TN-score was an independent prognostic factor for 5-year DFS. Only high-risk TN was associated with poor prognosis. High-risk TN “up-staged” the patients with IBC. Incorporating TN-score into staging category could improve its performance to stratify patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10943-x. |
format | Online Article Text |
id | pubmed-10257329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102573292023-06-11 Prognostic value of tumor necrosis based on the evaluation of frequency in invasive breast cancer Chen, Jianhua Li, Zhijun Han, Zhonghua Kang, Deyong Ma, Jianli Yi, Yu Fu, Fangmeng Guo, Wenhui Zheng, Liqin Xi, Gangqin He, Jiajia Qiu, Lida Li, Lianhuang Zhang, Qingyuan Wang, Chuan Chen, Jianxin BMC Cancer Research BACKGROUND: Tumor necrosis (TN) was associated with poor prognosis. However, the traditional classification of TN ignored spatial intratumor heterogeneity, which may be associated with important prognosis. The purpose of this study was to propose a new method to reveal the hidden prognostic value of spatial heterogeneity of TN in invasive breast cancer (IBC). METHODS: Multiphoton microscopy (MPM) was used to obtain multiphoton images from 471 patients. According to the relative spatial positions of TN, tumor cells, collagen fibers and myoepithelium, four spatial heterogeneities of TN (TN1-4) were defined. Based on the frequency of individual TN, TN-score was obtained to investigate the prognostic value of TN. RESULTS: Patients with high-risk TN had worse 5-year disease-free survival (DFS) than patients with no necrosis (32.5% vs. 64.7%; P < 0.0001 in training set; 45.8% vs. 70.8%; P = 0.017 in validation set), while patients with low-risk TN had a 5-year DFS comparable to patients with no necrosis (60.0% vs. 64.7%; P = 0.497 in training set; 59.8% vs. 70.8%; P = 0.121 in validation set). Furthermore, high-risk TN “up-staged” the patients with IBC. Patients with high-risk TN and stage I tumors had a 5-year DFS comparable to patients with stage II tumors (55.6% vs. 62.0%; P = 0.565 in training set; 62.5% vs. 66.3%; P = 0.856 in validation set), as well as patients with high-risk TN and stage II tumors had a 5-year DFS comparable to patients with stage III tumors (33.3% vs. 24.6%; P = 0.271 in training set; 44.4% vs. 39.3%; P = 0.519 in validation set). CONCLUSIONS: TN-score was an independent prognostic factor for 5-year DFS. Only high-risk TN was associated with poor prognosis. High-risk TN “up-staged” the patients with IBC. Incorporating TN-score into staging category could improve its performance to stratify patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10943-x. BioMed Central 2023-06-09 /pmc/articles/PMC10257329/ /pubmed/37296414 http://dx.doi.org/10.1186/s12885-023-10943-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Chen, Jianhua Li, Zhijun Han, Zhonghua Kang, Deyong Ma, Jianli Yi, Yu Fu, Fangmeng Guo, Wenhui Zheng, Liqin Xi, Gangqin He, Jiajia Qiu, Lida Li, Lianhuang Zhang, Qingyuan Wang, Chuan Chen, Jianxin Prognostic value of tumor necrosis based on the evaluation of frequency in invasive breast cancer |
title | Prognostic value of tumor necrosis based on the evaluation of frequency in invasive breast cancer |
title_full | Prognostic value of tumor necrosis based on the evaluation of frequency in invasive breast cancer |
title_fullStr | Prognostic value of tumor necrosis based on the evaluation of frequency in invasive breast cancer |
title_full_unstemmed | Prognostic value of tumor necrosis based on the evaluation of frequency in invasive breast cancer |
title_short | Prognostic value of tumor necrosis based on the evaluation of frequency in invasive breast cancer |
title_sort | prognostic value of tumor necrosis based on the evaluation of frequency in invasive breast cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257329/ https://www.ncbi.nlm.nih.gov/pubmed/37296414 http://dx.doi.org/10.1186/s12885-023-10943-x |
work_keys_str_mv | AT chenjianhua prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer AT lizhijun prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer AT hanzhonghua prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer AT kangdeyong prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer AT majianli prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer AT yiyu prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer AT fufangmeng prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer AT guowenhui prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer AT zhengliqin prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer AT xigangqin prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer AT hejiajia prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer AT qiulida prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer AT lilianhuang prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer AT zhangqingyuan prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer AT wangchuan prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer AT chenjianxin prognosticvalueoftumornecrosisbasedontheevaluationoffrequencyininvasivebreastcancer |